This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Updated February 26, 2016. The goal over the next 5 years is to shift from animal testing being a requirement to being an exception. 3,6 REFERENCES FDA drug approval process infographic (horizontal). Accessed June 19, 2025. link] Consolidated Appropriations Act of 2023, HR 2617, 117th Cong (2023). Accessed June 23, 2025.
The 2016 World Health Organization classification of MCL recognizes 2 molecular subtypes that reflect divergent pathogenesis and clinical behavior 2 : Classical MCL is derived from naive B cells that lack somatic hypermutation in IGHV , do not transit through the germinal center, and express the SOX11 transcription factor.
Within the pharmacy, the average appointment time for contraception prescribing is just 20 minutes, and Meredith highlighted the importance of involving pharmacy technicians to streamline the workflow. 1 Meredith also cited promising outcomes from states like Oregon.
FDA for CAPLYTA® (lumateperone) with data demonstrating significant schizophrenia relapse prevention compared to placebo. July 8, 2025. Nasrallah, H. Bossie, C. Hough, D., & & Turkoz, I. Factors associated with relapse in schizophrenia despite adherence to long-acting injectable antipsychotic therapy.
1,2 To better understand this relationship, researchers assessed 4754 patients with CLL/SLL who were treated with either venetoclax and obinutuzumab from April 2016 to August 2022 (n = 2104) or zanubrutinib from November 2019 to August 2023 (n = 2650).
Ross et al published a landmark study in 2016 evaluating psilocybin’s impact on anxiety and depression in 51 patients with life-threatening cancer. It triggered an outflow of new psychedelic research interest and added evidence to the relationship between mystical experience and the efficacy of psilocybin.
SHOW MORE The study found biosimilar initiation rose to nearly 42% from 2016 to 2023. 1 For this retrospective cohort study, the investigators collected data from January 1, 2016, to December 31, 2023, to assess the uptake of biosimilars within the pediatric IBD space. One patient started Inflectra in 2016 and 2017.
031), and diagnosis between 2016 and 2018 (OR 1.93, P < 001) as well as 2019 and 2020 (1.88, P < 001). in 2016, representing a period of rapid uptake—and usage was consistently high from 2016 to 2018. 3 The utilization of HER2 therapies increased from 64.6% in 2013 to 80.9%
1 Scientific evidence between January 1, 2016, and January 31, 2023, was included in the study. This was assessed by analyzing real-world pharmacoepidemiological data and conducting a systematic review and meta-analysis to further quantify this risk.
14, 2023) – In honor of Amber SpecialtyPharmacy’s 25th anniversary, the specialtypharmacy provider has launched Vitality, a new six-month transplant recovery program to help support patients and caregivers during the post-transplant period, which is considered the most critical time for those patients.
Why a SpecialtyPharmacy? Overview) As chronic illnesses become increasingly common in the United States, the number of specialty medications for managing these conditions has skyrocketed. Which is why, according to some online reports, nearly 80% of new drug introductions are now specialty medications. Better Incomes.
Why a SpecialtyPharmacy? Overview) As chronic illnesses become increasingly common in the United States, the number of specialty medications for managing these conditions has skyrocketed. Which is why, according to some online reports, nearly 80% of new drug introductions are now specialty medications. Better Incomes.
Why a SpecialtyPharmacy? Overview) As chronic illnesses become increasingly common in the United States, the number of specialty medications for managing these conditions has skyrocketed. Which is why, according to some online reports, nearly 80% of new drug introductions are now specialty medications. Better Incomes.
Southwest Mississippi Regional Medical Center’s ( SMRMC ) Tiffany Poole earned her Doctorate of Pharmacy degree from the University of Mississippi in 2006. A ProxsysRx pharmacist since 2018, she joined SMRMC (in McComb, MS) as an oncology pharmacist in 2016 — and was promoted to Director of Pharmacy in June, 2021.
3 (2016): 511520, published in final edited form September 2016, [link] 2 Andrew S. 2 (2021): 78148, [link] 37 Tasmina Hydery and Vimal Reddy, “Tiered Formulary Structures and Their Impact on Medication Access,” Journal of Managed Care & SpecialtyPharmacy 30, no. 14 National Health Council. 2024.30.2.206.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content